IE802533L - Cancer cell antigens - Google Patents
Cancer cell antigensInfo
- Publication number
- IE802533L IE802533L IE802533A IE253380A IE802533L IE 802533 L IE802533 L IE 802533L IE 802533 A IE802533 A IE 802533A IE 253380 A IE253380 A IE 253380A IE 802533 L IE802533 L IE 802533L
- Authority
- IE
- Ireland
- Prior art keywords
- antibodies
- human cancer
- nucleolar antigen
- antisera
- specific
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/57595—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving intracellular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Detergent Compositions (AREA)
Abstract
DETECTION OF HUMAN CANCER CELLS WITH ANTIBODIES TO HUMAN CANCER NUCLEOLAR ANTIGEN(S) Specific common nucleolar antigen(s) are found in a broad range of human malignant tumor specimens and have been isolated, extracted and purified. Antibodies and antisera specific to these nucleolar antigen(s) are harvested from non-human hosts and used for detection of human cancer cells. Disclosed are (1) methods for isolating the nucleolar antigen(s), obtaining them in substantially purified form, producing the specific antibodies, obtaining them in substantially purified form, and using the antisera and antibodies induced by the nucleolar antigen(s) in diagnostic procedures for detecting human cancer cells, and (2) diagnostic kits comprising specific antibodies and antisera.
[CA1157373A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000343088A CA1157373A (en) | 1980-01-04 | 1980-01-04 | Detection of human cancer cells with antibodies to human cancer nucleolar antigen(s) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE802533L true IE802533L (en) | 1981-07-04 |
| IE50760B1 IE50760B1 (en) | 1986-07-09 |
Family
ID=4115973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2533/80A IE50760B1 (en) | 1980-01-04 | 1980-12-04 | Detection of human cancer cells with antibodies to human cancer nucleolar antigens |
Country Status (27)
| Country | Link |
|---|---|
| JP (1) | JPS56101553A (en) |
| KR (1) | KR850001770B1 (en) |
| AR (1) | AR232046A1 (en) |
| AT (1) | AT373397B (en) |
| AU (1) | AU535024B2 (en) |
| BE (1) | BE886935A (en) |
| CA (1) | CA1157373A (en) |
| CH (1) | CH659328A5 (en) |
| DE (1) | DE3047654A1 (en) |
| DK (1) | DK554980A (en) |
| ES (2) | ES498305A0 (en) |
| FI (1) | FI810007A7 (en) |
| FR (1) | FR2484650B1 (en) |
| GB (1) | GB2067286B (en) |
| GR (1) | GR72850B (en) |
| IE (1) | IE50760B1 (en) |
| IL (1) | IL61641A (en) |
| IT (1) | IT1172216B (en) |
| LU (1) | LU83015A1 (en) |
| NL (1) | NL8007128A (en) |
| NO (2) | NO803910L (en) |
| NZ (1) | NZ195756A (en) |
| OA (1) | OA06713A (en) |
| PH (5) | PH18765A (en) |
| PT (1) | PT72301B (en) |
| SE (1) | SE450665B (en) |
| ZA (1) | ZA807754B (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4487830A (en) * | 1982-05-14 | 1984-12-11 | American Hoechst Corporation | Enzyme/immunofluorescent assay for autoantibodies |
| JPS5990052A (en) * | 1982-11-16 | 1984-05-24 | Katsu Taniguchi | Melanoma diagnosis medicine using monoclonal specific antibody |
| US4871661A (en) * | 1983-11-23 | 1989-10-03 | The Ohio State University Research Foundation | Process for testing the carcinogenicity of a material or the presence of cancer-inducing factors in an environment |
| US4746539A (en) * | 1983-11-23 | 1988-05-24 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
| EP0145373B1 (en) * | 1983-11-23 | 1992-03-25 | The Ohio State University Research Foundation | Purification of cancer-associated protein and preparation of antibody thereto |
| US4645737A (en) * | 1984-03-05 | 1987-02-24 | American Hoechst Corporation | Enzyme/immunofluorescent assay for anti-treponemal antibodies |
| US4607008A (en) * | 1984-03-05 | 1986-08-19 | American Hoechst Corporation | Enzyme/immunofluorescent assay for anti-Epstein-Barr Virus antibodies |
| EP0162977B1 (en) * | 1984-05-02 | 1992-05-20 | University Research Corporation | Enzyme immunoassay for cancer procoagulant |
| US4616658A (en) * | 1985-02-27 | 1986-10-14 | William Shell | Non-radioactively labeled microspheres and use of same to measure blood flow |
| US4798719A (en) * | 1986-09-11 | 1989-01-17 | University Of Pittsburgh | Method for selection of antigens suitable as in vivo targets for antibodies |
| US5019368A (en) * | 1989-02-23 | 1991-05-28 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| US4861581A (en) * | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
| CA2023030A1 (en) * | 1990-07-13 | 1992-01-14 | Robert R. Guerrero | In vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals |
-
1980
- 1980-01-04 CA CA000343088A patent/CA1157373A/en not_active Expired
- 1980-12-04 NZ NZ195756A patent/NZ195756A/en unknown
- 1980-12-04 AU AU65070/80A patent/AU535024B2/en not_active Ceased
- 1980-12-04 IE IE2533/80A patent/IE50760B1/en unknown
- 1980-12-05 IL IL61641A patent/IL61641A/en unknown
- 1980-12-10 ZA ZA00807754A patent/ZA807754B/en unknown
- 1980-12-15 PH PH24978A patent/PH18765A/en unknown
- 1980-12-17 DE DE19803047654 patent/DE3047654A1/en active Granted
- 1980-12-18 LU LU83015A patent/LU83015A1/en unknown
- 1980-12-22 AR AR283753A patent/AR232046A1/en active
- 1980-12-22 NO NO803910A patent/NO803910L/en unknown
- 1980-12-27 JP JP18948880A patent/JPS56101553A/en active Pending
- 1980-12-29 DK DK554980A patent/DK554980A/en not_active Application Discontinuation
- 1980-12-30 KR KR1019800005026A patent/KR850001770B1/en not_active Expired
- 1980-12-30 CH CH9652/80A patent/CH659328A5/en not_active IP Right Cessation
- 1980-12-31 BE BE0/203378A patent/BE886935A/en not_active IP Right Cessation
- 1980-12-31 NL NL8007128A patent/NL8007128A/en not_active Application Discontinuation
- 1980-12-31 PT PT72301A patent/PT72301B/en unknown
- 1980-12-31 GB GB8041638A patent/GB2067286B/en not_active Expired
-
1981
- 1981-01-02 SE SE8100011A patent/SE450665B/en not_active IP Right Cessation
- 1981-01-02 FI FI810007A patent/FI810007A7/en not_active Application Discontinuation
- 1981-01-02 FR FR8100014A patent/FR2484650B1/en not_active Expired
- 1981-01-02 ES ES498305A patent/ES498305A0/en active Granted
- 1981-01-05 IT IT67001/81A patent/IT1172216B/en active
- 1981-01-05 GR GR63789A patent/GR72850B/el unknown
- 1981-01-05 AT AT0001081A patent/AT373397B/en not_active IP Right Cessation
- 1981-01-05 OA OA57289A patent/OA06713A/en unknown
-
1982
- 1982-02-01 ES ES509239A patent/ES509239A0/en active Granted
-
1983
- 1983-02-21 PH PH28549A patent/PH18636A/en unknown
- 1983-02-21 PH PH28548A patent/PH18624A/en unknown
- 1983-02-21 PH PH28547A patent/PH18637A/en unknown
- 1983-02-21 PH PH28550A patent/PH18129A/en unknown
-
1985
- 1985-01-02 NO NO850005A patent/NO850005L/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8307377A1 (en) | Detection of human cancer cells with antibodies to human cancer cell nucleolar antigen(s) | |
| GR81951B (en) | ||
| DE3789781D1 (en) | Antigens, antibodies and methods for identifying human metastatic tumors and cell lines for the production of these antibodies. | |
| GB2182949A (en) | Monoclonal antibodies and antigens for human non-small cell lung carcinomas | |
| DE3376360D1 (en) | Fucosyl antigens, a process for their preparation and antibodies for recognising them, a cancer diagnosing kit containing the fucosyl antigens and a method for determination of cancer associated carbohydrate linkages | |
| DE3069404D1 (en) | Radioimmunoassay of migration inhibitory factor | |
| EP0226468A3 (en) | Detection of human cancer cells with antibodies to human cancer nucleolar antigen p145 | |
| GB8611982D0 (en) | Monoclonal antibodies | |
| Herberman | Delayed hypersensitivity skin reactions to antigens on human tumors | |
| DE3160694D1 (en) | Process for obtaining toxoplasma preparations for the toxoplasmosis diagnosis, and preparations so obtained | |
| EP0248147A3 (en) | Method of determining the presence of cancer cells | |
| EP0143367A3 (en) | Method for production of monoclonal antibodies for cancer diagnosis and therapy | |
| WO1986002651A3 (en) | Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells | |
| Wada et al. | Thymus lymphocytes in rats during induction of bladder tumors and effects of thymosin fraction 5 in vitro | |
| Merry et al. | A rapid purification method for peanut anti-T lectin | |
| EP0356397A3 (en) | Monoclonal antibodies against, and cell surface antigen of, lung carcinoma | |
| Fink et al. | Reactivity of serum from frogs and other species with a herpesvirus antigen extracted from a Burkitt lymphoma cultured cell line | |
| EP0275705A3 (en) | Monoclonal antibodies specific for human basal cells, scc and precancerous cells | |
| JPS5616415A (en) | Preparation of antibody | |
| Wintzer et al. | New lectin receptors in carcinoembryonic antigen (CEA) | |
| IL67944A0 (en) | Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same |